纯Mo及钼基可降解金属材料的研究现状与发展趋势
郑玉峰, 谌雨农

Research Status and Future Directions of Pure Mo and Mo-Based Biodegradable Metals
ZHENG Yufeng, SHEN Yunong
图6 含Mo生物材料应用于骨科器械的实验结果:实物照片和Micro-CT分析显示7.5Mo-BGC (生物活性玻璃陶瓷)支架在第12周相较于空白组和BGC组具有更优的骨软骨修复效果[89];第12周的番红O染色结果显示7.5Mo-BGC组形成了更多透明软骨样组织[89];Micro-CT及三维重建证实在第1和第8周支架的保留、新骨形成及新骨向Mo支架内的长入[90];组织学染色显示新形成的骨-牙周膜-牙骨质复合体[91];免疫荧光结果提示在再生牙周膜内有成纤维连接蛋白骨膜蛋白的表达[92];组织学测量分析显示牙周再生相关参数得到改善[91];免疫荧光进一步显示在骨-牙周膜及牙周膜-牙根界面处存在神经标志物(CGRP、TRPV、TRPM8)的表达[91];RAW 264.7细胞在Mmp9抑制剂(Ilomastat)处理下的免疫荧光图像[92];及巨噬细胞对可降解钼植入物降解产物炎症反应的示意图[92]
Fig.6 Experiment results on the application of molybdenum-containing biomaterials in orthopedic devices
(a) digital photographs and micro-CT analyses demonstrated superior osteochondral repair with 7.5Mo-BGC scaffolds versus blank and BGC groups at 12 weeks[89] (BGC—bioactive glass ceramic)
(b) safranin O staining at week 12 revealed increased hyaline cartilage-like tissue in the 7.5Mo-BGC group[89]
(c, d) micro-CT and 3D reconstructions confirmed scaffold retention, new bone formation, and bone ingrowth into Mo-scaffolds at 1 (c) and 8 (d) weeks[90] (BG-scaffold—bioactive glass ceramic scaffold without molybdenum. Green arrows in Fig.6d show the newly formed bones)
(e) histological staining demonstrated newly formed bone-periodontal ligament-cementum complexes[91] (BRH—bone regeneration height, CRH—cementum regeneration height, PD—probing depth, GR—gingival recession, AL—attachment loss, DH—distance from the cementoenamel junction to bottom of defect)
(f) immunofluorescence indicated periostin expression across regenerated periodontium[91]
(g) histometric analyses revealed enhanced periodontal regeneration parameters[91]
(h) immunofluorescence further showed expression of neuronal markers (CGRP, TRPV, and TRPM8) at bone-ligament and ligament-root interfaces[91]
(i) immunofluorescence images of RAW 264.7 cells treated with Mmp9 inhibitor (Ilomastat)[92] (R-Mo—rolled molybdenum, DAPI—4',6-diamidino-2-phenylindole, Mmp9—matrix metalloproteinase 9)
(j) schematic of macrophage-related inflammatory responses to degradation products of biodegradable molybdenum implants[92]